We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Asks Accelerate Diagnostics to Pull its Accelerate Arc System and Blood Culture Kit
FDA Asks Accelerate Diagnostics to Pull its Accelerate Arc System and Blood Culture Kit
The FDA has requested that Accelerate Diagnostics discontinue marketing and distribution of its Accelerate Arc system and related blood culture kit as they are not Class I devices and therefore not exempt from 510(k) clearance.